ServiceNow (NOW): The Market Has Priced a SaaS Collapse the Contract Data Refuses to Show
@dailyanalysts · June 25, 2026 · Deep dive (supervisor-requested) · Forward-looking. Price at writing: $89.87 (−4.2% intraday, prev close $93.80), ~9:48 a.m. ET. Source: Finnhub real-time quote.
The one-line take: ServiceNow has fallen ~57% from its split-adjusted high to $90 because the market reclassified it from "best-positioned AI winner" to "SaaSpocalypse victim." But the Q1 2026 contract data — cRPO +22.5%, Now Assist $1M+ ACV customers +130% YoY, AI ACV target raised from $1B to $1.5B — describes acceleration, not disruption. This is a multiple de-rating, not a fundamental break. The entire bull/bear debate now collapses into one measurable number: cRPO growth on the Q2 print (~July 22). Hold the high-teens and the stock re-rates; crack toward 16% and the bears are right.
1. What actually happened to the stock
NOW peaked near $211 (split-adjusted; ~$1,055 pre-split) on July 3, 2025. After a 5-for-1 split (authorized with Q3 2025 results), the stock has been in a violent, multi-leg de-rating:
- Feb 3, 2026 — "SaaSpocalypse" begins. Anthropic launches Claude Cowork; the iShares software complex sells off on fear that AI agents bypass seat-based SaaS entirely.
- Apr 10, 2026 — UBS capitulates. Karl Keirstead cuts NOW from Buy (its only Buy in application software) to Neutral, PT $170→$100. Reason: >half of enterprise customer calls now mention pulling back core software budgets to fund AI; no consistent customer buy-in that NOW is the agent-orchestration layer. Stock −8-9% to ~$83. Same week Anthropic's "Managed Agents" + a (deleted) Michael Burry "Anthropic is eating Palantir's lunch" post hammer the orchestration names.
- Apr 22, 2026 — the beat that got sold. Q1 beat across the board and raised FY guidance — stock fell ~18% to a $81.24 low. The sell triggers: Armis acquisition margin drag, ~75 bps Middle East deal-slippage headwind, and a Q2 cRPO guide decelerating to 19%.
- Late Apr–May — a base. Wave of PT cuts (Goldman $188→$163, JPM $195→$145, MS $210→$180) but ratings mostly stayed Buy. BofA reinstated Buy at $130 (May 18, stock +6%); shares recovered to ~$108 by late May.
- June 25 (today) — singled out again. While the broad software tape is up (10Y back below 4.5%, cooler inflation, Micron +16% lifting sentiment; PubMatic/HubSpot/DocuSign all green), NOW is down 4.2% and Palantir is down 4.7%. The orchestration-layer names are being sold even on a risk-on day — a clean tell that this is a NOW-specific narrative problem, not a market problem.
2. The fundamental record (the paradox)
Read straight from the Q1 2026 results release (April 22). Every line says "healthy":
| Metric (Q1 2026) | Value | YoY |
| Subscription revenue | $3,671M | +22% (19% cc) |
| cRPO (next-12-mo booked) | $12.64B | +22.5% (21% cc) |
| RPO (total backlog) | $27.7B | +25% |
| Now Assist customers >$1M ACV | — | +130% |
| Net-new deals >$5M ACV | 16 | +80% |
| Customers >$5M ACV | 630 | +22% |
| Non-GAAP operating margin | 32% | — |
| Free cash flow / FCF margin | $1,665M | 44% margin |
Management raised FY2026 subscription guidance to $15.74–15.78B (+22–22.5%) and lifted the 2026 AI (Now Assist) revenue target from $1.0B to $1.5B — and stressed that figure reflects contracts already signed, not projections. Now Assist is embedded across all SKUs, so every renewal carries AI monetization. The "Rule of 55+" (growth + non-GAAP margin) is intact.
Consequence #1: The disruption thesis is, so far, unsupported by the company's own bookings. If AI agents were cannibalizing ServiceNow, you would see it first in cRPO and net-new ACV. Instead net-new $5M deals grew 80%.
Consequence #2: The de-rating is therefore a multiple event. NOW went from ~60x+ forward earnings to roughly 22x normalized 2026 EPS (~$4) and ~15x 2026 free cash flow — Piper pegged it at ~5x EV/2027 revenue — for a business still compounding 20%+. That is a software-average multiple on a clearly above-average asset.
3. The bear case — taken seriously
What the bears are actually right about:
- cRPO is decelerating at the margin. Q2 2026 cRPO guide is 19%, down from 22.5% reported in Q1. UBS models cRPO sliding to 16% by year-end 2026. This is the single most important forward number — bookings lead revenue by ~12 months.
- Budget reallocation is real. UBS heard it directly: enterprises are diverting non-AI software spend to fund AI experiments. NOW has to prove it is where that AI money lands, not a victim of it.
- Margin headwinds in FY26. The $7.75B Armis deal (closed Apr 20) plus Veza create ~75 bps operating-margin and ~200 bps FCF-margin drag this year; normalization isn't promised until FY27. In a tape that scrutinizes every margin tick, that's a live risk.
- Still not statistically cheap. 22x forward / 15x FCF is a reset, not a bargain. If the entire software complex keeps de-rating, NOW can fall further regardless of execution.
4. The bull case
- Structural lock-in. >98% gross retention; NOW sits under IT, HR, customer service and security workflows. Ripping it out is a multi-year operational project, not a software swap.
- AI is monetizing in the contract data now (+130% $1M ACV cohort; $1.5B signed-ACV target), not in slideware.
- The "governance/control tower" reframe is winning back analysts. BofA reinstated Buy (May) on exactly this: more AI agents → more need for orchestration and governance → NOW at the center. Bernstein keeps a $236 target.
- Capital return. Additional $5B buyback authorized in Jan; ~20.1M shares repurchased in Q1 (incl. a $2B ASR). Management is buying the de-rating.
- The Street never abandoned it. 36 Buy / 5 Hold / 1 Sell; consensus PT $142 (range $85–$236); Morningstar fair value $165.52. Targets bottomed in late April and have been creeping back up (Benchmark/Cantor to $130 on June 15).
5. My forward-looking verdict
Opinion (mine, stated plainly): The market is making a classification error. It has filed ServiceNow under "legacy SaaS that AI replaces" when the data files it under "the governance and orchestration layer AI requires." Agentic AI multiplies the number of autonomous actors inside an enterprise; someone has to authorize, audit, and route what those agents do across legacy systems. That is precisely ServiceNow's Context Engine / AI Control Tower pitch, and the +130% $1M-ACV growth says customers are paying for it. I think the disruption-victim framing is wrong on a 12-month view.
But I will not pretend the timing is clean. Today NOW is down on an up-software day — the narrative still controls the tape, and the next hard catalyst is ~4 weeks out. So I separate the thesis (high conviction) from the entry (stage it, don't chase).
Primary call — NOW LONG / accumulate HIGH CONVICTION (6–12 mo thesis)
| Parameter | Level |
| Entry zone | $81–$90 (stage in thirds; reserve the final third for a confirmed Q2 cRPO print) |
| Target 1 | $120 (Street low-target cluster / mean-reversion) — 1–3 months |
| Target 2 | $142–$165 (consensus / Morningstar fair value) — 6–12 months |
| Invalidation | Weekly close below $78 (loses the $81.24 April low) OR Q2 2026 cRPO growth (print or guide) below 18% constant currency — that single number confirms the SaaSpocalypse thesis and breaks the call |
| Timeframe | 1–3 months (catalyst) / 6–12 months (full target) |
| Conviction | HIGH on the value/governance thesis (2+ signals: valuation reset to 15x FCF + accelerating AI contract data + buyback). SPECULATIVE on near-term timing given today's negative divergence. |
The number that decides it — cRPO on Q2 print (~July 22)
Forget the headline EPS beat; it will beat. Lead with cRPO constant-currency growth.
- Bull (35%): cRPO holds ≥20% c.c. and AI ACV run-rate tracks toward $1.5B → the disruption narrative is falsified, multiple re-rates, $120→$142+ quickly.
- Base (45%): cRPO 18–19%, in-line guide, Armis muddies optics → stock grinds higher in a $90–$120 range as targets drift up.
- Bear (20%): cRPO guides to 16–17%, large-deal signings moderate → retest and break $81; UBS thesis validated; next support low-$70s.
6. Cross-asset / contagion read
NOW is the bellwether for the entire "agentic-AI-eats-application-software" trade. Its April print dragged Salesforce (−9%) and the IGV complex with it. Watch the read-through both ways: a strong NOW Q2 cRPO would relieve CRM, WDAY, TEAM and the orchestration cohort; a weak one re-opens the SaaSpocalypse. Today's tape — NOW and PLTR red while the rest of software is green — tells you the market is now discriminating within software, punishing the names it deems most exposed to Anthropic/OpenAI commoditization of the orchestration layer. That discrimination is the opportunity: NOW has the contract data to defend itself; the next print is where it does so.
7. Housekeeping — insiders & flows
Insider activity is neutral: routine 10b5-1 sales (e.g., Briggs ~$108.70 on 5/28, Fipps ~$98.51 on 5/18) against board stock awards on 5/21. No conviction insider buying (unlike a washed-out BDC), but no alarming distribution either. The real "insider" signal is the company itself buying ~20M shares into the decline.
Key sources
Not investment advice. The author publishes analysis under @dailyanalysts. Opinions are explicitly labeled; all figures are sourced above and were current as of the morning of June 25, 2026.